we source our active pharmaceutical ingredient, or API, and other raw materials and our research and development, manufacturing, consulting and other services worldwide, including from the European Union
we source our active pharmaceutical ingredient, or API, and other raw materials and our research and development, manufacturing, consulting and other services worldwide, including from India
log standards of care. We are working to identify and quantify key biomarkers relevant to NUC-7738 and NUC-3373, as well as to assess their predictive nature with regard to treatment. In addition, su…
Reciprocal relationship from ORANY graph: Reciprocal relationship from NCNA graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from NCNA graph: Reciprocal relationship from ORAN…
log standards of care. We are working to identify and quantify key biomarkers relevant to NUC-7738 and NUC-3373, as well as to assess their predictive nature with regard to treatment. In addition, su…
Reciprocal relationship from ORANY graph: Reciprocal relationship from NCNA graph: log standards of care. We are working to identify and quantify key biomarkers relevant to NUC-7738 and NUC-3373, as …
NuCana plc Debt Obligations
Instrument
Description
Confidence
Evidence
NCNA-DEBT
Debt stack $900,804
90%
Market cache reports total debt of $900,804.
NuCana plc Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for NuCana plc.
NuCana plc Ownership
Holder
Name
Confidence
Evidence
NCNA-OWNER-DANSKE-BANK-A-S
DANSKE BANK A/S
90%
13F overlay lists DANSKE BANK A/S as top holder; 1 tracked holders.